Medtelligence

Prevention of ASCVD in Women Through Lipid Management in the New Era

Prevention of ASCVD in Women Through Lipid Management in the New Era
RestartResume

There are now more options than ever for treating cardiovascular disease! Our lipid management experts will fill you in on the latest developments.

Available credits: 0.25

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    This activity will you improve your knowledge, awareness, competency, and strategies for women with or at high risk of atherosclerotic cardiovascular disease (ASCVD). Topics covered include the recent AHA/ACC/Multisociety Blood Cholesterol Guidelines. Also discussed are the new options for lowering LDL-C, and how treatment for patients with hypertriglyceridemia has redefined lipid management. The faculty, Drs. Erin Michos and Eliot Brinton, expertly review information on managing women with risk of ASCVD.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Faculty:
    Eliot A. Brinton, MD, FAHA, FNLA, FACE
    President
    Utah Lipid Center
    Salt Lake City, UT

    Consulting Fees: Amarin, Esperion, Kowa
    Commercial Interest Speakers Bureau: Amarin, Amgen, Boehringer Ingelheim, Kowa, Merck, Nova, Regeneron, Sanofi 

    Erin D. Michos, MD, MHS, FACC, FAHA, FASE
    Associate Professor of Medicine and Epidemiology
    Director of Women's Cardiovascular Health
    Associate Director of Preventive Cardiology
    Associate Faculty of the Welch Center for Prevention, Epidemiology, and Clinical Research
    Division of Cardiology
    Johns Hopkins University School of Medicine
    Baltimore, MD
    No relationships reported

    Reviewers/Content Planners/Authors:

    • Ben Caref, PhD, has nothing to disclose.
    • Sue Grossman has nothing to disclose.
    • Kathy Wickman has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Screen and diagnose female patients at high risk of cardiovascular events during their annual visit
    • Describe the importance of triglyceride management in ASCVD risk assessment and management
    • Apply evidence-based guidelines and recent randomized clinical trial evidence of icosapent ethyl in addition to statin therapy to manage women at risk of ASCVD events
  • Target Audience

    This course is designed to meet the educational needs of physicians, nurse practitioners, physician assistants, nurses, and certified nurse midwives in the fields of obstetrics and gynecology, family practice, and internal medicine.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Dedicated to the creation and execution of the highest quality, evidence-based continuing medical education (CME) initiatives, we utilize multiple learning opportunities for the primary goal of improving healthcare delivered to patients through sharing of research, knowledge, and clinical practice skills.

  • Commercial Support

    This activity is supported by an independent educational grant from Amarin Pharma, Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medtelligence. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Medtelligence you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Register

We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free